This webinar will explore several strategies for extending sample stability, alternatives to whole blood samples in flow cytometry, and their successful implementations in clinical studies.
On this episode of GEN Live, John Cumbers, PhD, CEO of SynBioBeta and Shelby Newsad, PhD, Investor at the Venture Capital firm Compound, join us for a broad discussion on the state of synbio where the field is now and where it’s heading.
In this GEN webinar, we will hear how our distinguished guest, Dr. David Öling, and his team set out to optimize DNA construct development, fully aware that if they cracked the code on accelerating this step, it would affect all downstream processes and speed up early drug discovery.
In this GEN webinar, our distinguished speaker Dr. Nicholas Valiante, will provide insights into designing, developing, and manufacturing mRNA vaccines to maximize performance. Dr. Valiante will expand on the process to evaluate and select ionizable lipids required for mRNA-LNP vaccines development.
In this GEN webinar, our distinguished guests, Dr. Agne Antanaviciute and Stefan Zaharievski, will describe how a novel alternative to traditional cell sorting and labeling LeviCell can be used to improve significantly single-cell data quality and cell recoveries in complex clinical tissue samples.